Skip navigation Scroll to top

Scroll to top

Roche confident after strong annual start

April 11, 2013

Roche confirmed its 2013 sales forecast after a “strong start to the new year,” according to CEO Severin Schwan. In Q1, sales increased 5.1% to CHF11.6bn, on strong demand for cancer medicines and clinical laboratory products as well as higher sales of antiviral drug Tamiflu in North America, topping the CHF11.5bn analysts’ consensus.